These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 25976432)

  • 1. Neuropathobiology of non-motor symptoms in Parkinson disease.
    Jellinger KA
    J Neural Transm (Vienna); 2015 Oct; 122(10):1429-40. PubMed ID: 25976432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synuclein deposition and non-motor symptoms in Parkinson disease.
    Jellinger KA
    J Neurol Sci; 2011 Nov; 310(1-2):107-11. PubMed ID: 21570091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathology of Nonmotor Symptoms of Parkinson's Disease.
    Jellinger KA
    Int Rev Neurobiol; 2017; 133():13-62. PubMed ID: 28802920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease as a multisystem disorder.
    Klingelhoefer L; Reichmann H
    J Neural Transm (Vienna); 2017 Jun; 124(6):709-713. PubMed ID: 28155133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
    Brain Struct Funct; 2014 Sep; 219(5):1513-26. PubMed ID: 24135772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brainstem pathology and non-motor symptoms in PD.
    Grinberg LT; Rueb U; Alho AT; Heinsen H
    J Neurol Sci; 2010 Feb; 289(1-2):81-8. PubMed ID: 19758601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
    Holmqvist S; Chutna O; Bousset L; Aldrin-Kirk P; Li W; Björklund T; Wang ZY; Roybon L; Melki R; Li JY
    Acta Neuropathol; 2014 Dec; 128(6):805-20. PubMed ID: 25296989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers.
    Cersosimo MG; Benarroch EE
    J Neurol Sci; 2012 Feb; 313(1-2):57-63. PubMed ID: 22001247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
    Jellinger KA
    Mov Disord; 2012 Jan; 27(1):8-30. PubMed ID: 22081500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of non-motor features of Parkinson disease.
    Dickson DW; Fujishiro H; Orr C; DelleDonne A; Josephs KA; Frigerio R; Burnett M; Parisi JE; Klos KJ; Ahlskog JE
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S1-5. PubMed ID: 20082965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-motor extranigral signs and symptoms in Parkinson's disease.
    Wolters ECh
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autonomic nervous system as a source of biomarkers in Parkinson's disease].
    Pouclet H; Lebouvier T; Flamant M; Coron E; Neunlist M; Derkinderen P; Rouaud T
    Presse Med; 2012 Jul; 41(7-8):695-701. PubMed ID: 22284542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathomechanisms underlying Parkinson's disease.
    Jellinger KA
    Expert Rev Neurother; 2014 Feb; 14(2):199-215. PubMed ID: 24471711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.
    Compta Y; Valente T; Saura J; Segura B; Iranzo Á; Serradell M; Junqué C; Tolosa E; Valldeoriola F; Muñoz E; Santamaria J; Cámara A; Fernández M; Fortea J; Buongiorno M; Molinuevo JL; Bargalló N; Martí MJ
    J Neurol; 2015 Feb; 262(2):294-306. PubMed ID: 25380583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.
    Donaghy PC; McKeith IG
    Alzheimers Res Ther; 2014; 6(4):46. PubMed ID: 25484925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
    Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M
    Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.